Fig 4

Using time-series-modelling RSV estimates: preferred strategy based on cost-effectiveness analysis from the healthcare payers’ perspective

Note: The RSV vaccine price per dose assumed is €150. Spain: Valencia region in this analysis. Abbreviations: QALY: quality-adjusted life-year, EUR: euro